Is ceftriaxone effective in experimental brain ischemia/reperfusion injury?

Bratisl Lek Listy. 2020;121(12):858-863. doi: 10.4149/BLL_2020_141.

Abstract

Objective: The aim of the present study was to investigate the neuroprotective effect of ceftriaxone in a rat brain ischemia/reperfusion injury model.

Methods: The oxidative stress parameter, malondialdehyde (MDA) levels with or without ceftriaxone treatment in brain ischemia/reperfusion injured rats as well as in controls were measured in serum and brain tissue. Motor examinations of the rats were also performed. One-way Analysis of Variance (ANOVA) test was used for analysis. Duncan's Multiple Range Test was performed in multiple comparisons. p < 0.05 were considered statistically significant. RESULTS: The data of this study showed that ceftriaxone treatment reduced the MDA levels in brain tissues in ischemia/reperfusion injured rats. Moreover, Bederson motor scores were higher in the ceftriaxone treated group as compared to the ischemia group (p = 0.092).

Conclusion: These results suggest that ceftriaxone could be beneficial for the prevention of brain ischemia/reperfusion injury caused by acute arterial occlusion through reducing the tissue MDA level (Tab. 2, Fig. 5, Ref. 24).

Keywords: antioxidant; ceftriaxone; ischemia/reperfusion injury; neuroprotective stroke..

MeSH terms

  • Animals
  • Brain
  • Brain Ischemia* / drug therapy
  • Ceftriaxone / therapeutic use*
  • Malondialdehyde / analysis
  • Neuroprotective Agents / therapeutic use*
  • Oxidative Stress / drug effects
  • Rats
  • Reperfusion Injury* / drug therapy
  • Reperfusion Injury* / prevention & control

Substances

  • Neuroprotective Agents
  • Malondialdehyde
  • Ceftriaxone